Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 54.69% is in line with its 4-year average of 56.10%, around the middle of its 4-year range (49.14%–59.21%).
0.27% above its 12-month average of 54.54%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 58.22%.
GROSS MARGIN
54.69%
GROSS MARGIN AVG TTM
54.54%
GROSS MARGIN AVG 3Y
56.03%
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+0.27%
CURRENT VS 3Y AVG
-2.39%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-7.30%
vs the sector median at left
Solventum Corporation
Market Cap
$15.51B
Gross Margin
54.69%
TTM Avg
54.54%
3Y Avg
56.03%
5Y Avg
N/A
Market Cap
$16.27B
Gross Margin
28.76%
TTM Avg
30.59%
3Y Avg
29.65%
5Y Avg
29.57%
Market Cap
$13.19B
Gross Margin
32.24%
TTM Avg
31.70%
3Y Avg
34.15%
5Y Avg
35.17%
Market Cap
$18.02B
Gross Margin
61.62%
TTM Avg
66.54%
3Y Avg
68.95%
5Y Avg
69.55%
Market Cap
$12.54B
Gross Margin
30.08%
TTM Avg
33.76%
3Y Avg
35.72%
5Y Avg
36.84%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $15.51B | 54.69% | 54.54% | 56.03% | N/A |
| Medpace Holdings, Inc. (MEDP)vs › | $16.27B | 28.76% | 30.59% | 29.65% | 29.57% |
| Exelixis, Inc. (EXEL)vs › | $14.56B | 96.48% | 96.44% | 96.31% | 96.33% |
| Revvity, Inc. (RVTY)vs › | $13.61B | 52.11% | 50.55% | 50.58% | 52.43% |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.19B | 32.24% | 31.70% | 34.15% | 35.17% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.02B | 61.62% | 66.54% | 68.95% | 69.55% |
| Baxter International Inc. (BAX)vs › | $12.54B | 30.08% | 33.76% | 35.72% | 36.84% |
| Penumbra, Inc. (PEN)vs › | $12.57B | 67.84% | 65.17% | 64.50% | 63.66% |
| Viatris Inc. (VTRS)vs › | $18.90B | 34.83% | 36.61% | 38.73% | 36.31% |
| Encompass Health Corporation (EHC)vs › | $12.08B | 95.71% | 68.63% | 54.72% | 59.42% |
Gross Margin
54.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 58.22% |
| 2026-03-31 | 54.66% |
| 2025-12-31 | 49.30% |
| 2025-09-30 | 56.15% |
| 2025-06-30 | 54.37% |
| 2025-03-31 | 53.82% |
| 2024-12-31 | 53.93% |
| 2024-09-30 | 55.96% |
| 2024-06-30 | 54.64% |
| 2024-03-31 | 58.13% |
| 2023-12-31 | 56.88% |
| 2023-09-30 | 58.29% |
| 2023-06-30 | 57.27% |
| 2023-03-31 | 56.54% |
| 2022-12-31 | 49.14% |
| 2022-09-30 | 57.19% |
| 2022-06-30 | 59.21% |
| 2022-03-31 | 59.21% |
